Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $32.2300 (0.06%) ($31.6500 - $32.6200) on Fri. Jul. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.69% (three month average) | RSI | 68 | Latest Price | $32.2300(0.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.4% a day on average for past five trading days. | Weekly Trend | EDIT advances 3.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(61%) IWO(58%) ARKG(56%) IBUY(54%) IWC(54%) | Factors Impacting EDIT price | EDIT will decline at least -2.345% in a week (0% probabilities). VIXM(-28%) UUP(-15%) VXX(-12%) TBT(-7%) IYT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.345% (StdDev 4.69%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
5 Day Moving Average | $32.03(0.62%) | 10 Day Moving Average | $32.49(-0.8%) | 20 Day Moving Average | $31.82(1.29%) | To recent high | -6.9% | To recent low | 45.2% | Market Cap | $2.002b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |